Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

PRP treatment improves hair count, density, and reduces hair loss in AGA patients.

Tazarotene gel may be more effective for acne than adapalene gel.

PSI-MS quickly and accurately measures finasteride in tablets, helping with quality control.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

Risankizumab may help manage symptoms of dissecting cellulitis of the scalp.

Platelet-rich plasma is as effective as mineral trioxide aggregate for pulp capping and may offer better cellular responses.

Finasteride blocks progesterone's effect on absence seizures in rats.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

PRP's effectiveness for acne scars is uncertain.

Goat placenta extract in a special delivery system improved hair growth and thickness in chemotherapy patients.

Finasteride helps reduce pain and inflammation in animals.

Compound 4 is a promising treatment for hair loss with low toxicity.

Porcine PRP can replace FBS and may promote hair growth.

Microparticles containing artocarpin extract could effectively treat hair loss and acne with minimal side effects.

DPCP is effective for treating severe alopecia areata, but relapse is common.

SEPA™ enhances the effectiveness of minoxidil in stimulating hair growth, working faster and better than Rogaine® TS, with no significant side effects.

A new method was developed to measure and assess the activity and inhibition of the enzyme steroid 5α-reductase.

Three cost-effective methods accurately measure finasteride in pharmaceuticals, better than current techniques.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

PRP shows promise for spinal pain but needs more guidelines before widespread use.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.